BlackRock’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.6M | Buy |
2,022,150
+31,297
| +2% | +$210K | ﹤0.01% | 3191 |
|
|
2025
Q1 | $18M | Buy |
1,990,853
+16,401
| +0.8% | +$148K | ﹤0.01% | 2968 |
|
|
2024
Q4 | $34.1M | Buy |
1,974,452
+151,617
| +8% | +$2.62M | ﹤0.01% | 2665 |
|
|
2024
Q3 | $29.1M | Buy |
1,822,835
+128,968
| +8% | +$2.06M | ﹤0.01% | 2761 |
|
|
2024
Q2 | $24.1M | Buy |
1,693,867
+207,699
| +14% | +$2.96M | ﹤0.01% | 2816 |
|
|
2024
Q1 | $21.1M | Sell |
1,486,168
-16,369
| -1% | -$232K | ﹤0.01% | 2912 |
|
|
2023
Q4 | $22.7M | Buy |
1,502,537
+98,134
| +7% | +$1.48M | ﹤0.01% | 2889 |
|
|
2023
Q3 | $22.2M | Sell |
1,404,403
-1,403
| -0.1% | -$22.2K | ﹤0.01% | 2838 |
|
|
2023
Q2 | $21.3M | Buy |
1,405,806
+1,193,821
| +563% | +$18.1M | ﹤0.01% | 2946 |
|
|
2023
Q1 | $3.07M | Buy |
211,985
+23,991
| +13% | +$348K | ﹤0.01% | 3776 |
|
|
2022
Q4 | $2.54M | Buy |
187,994
+40,401
| +27% | +$546K | ﹤0.01% | 3954 |
|
|
2022
Q3 | $2.33M | Buy |
147,593
+82,594
| +127% | +$1.3M | ﹤0.01% | 4029 |
|
|
2022
Q2 | $791K | Sell |
64,999
-380,521
| -85% | -$4.63M | ﹤0.01% | 4537 |
|
|
2022
Q1 | $4.18M | Buy |
445,520
+1,094
| +0.2% | +$10.3K | ﹤0.01% | 3978 |
|
|
2021
Q4 | $7.61M | Buy |
+444,426
| New | +$7.61M | ﹤0.01% | 3750 |
|